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Abstract
Multipassage experiments are performed by subcutaneous implantation in lab animals (usually mice) of a small number of
cells from selected human lines. Tumor cells are then passaged from one mouse to another by harvesting them from a
growing tumor and implanting them into other healthy animals. This procedure may be extremely useful to investigate the
various mechanisms involved in the long term evolution of tumoral growth. It has been observed by several researchers
that, contrary to what happens in in vitro experiments, there is a significant growth acceleration at each new passage. This
result is explained by a new method of analysis, based on the Phenomenological Universalities approach. It is found that, by
means of a simple rescaling of time, it is possible to collapse all the growth curves, corresponding to the successive
passages, into a single curve, belonging to the Universality Class U2. Possible applications are proposed and the need of
further experimental evidence is discussed.
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Introduction
The fitting of any given set of experimental data may be just an
exercise to find, for practical purposes, a convenient analytical curve
to represent the data or, at a much deeper level, it may aim to
provide a model. In the latter case one should restrict one’s attention
to the raw data and analyse them independently of the field of
application, in order to extract from them unbiasedly every bit of
meaningfulinformation.Thistough requirementiswelldescribed by
the old adage ‘‘If you torture well enough your data, they’ll confess’’,
with the double-entendre that they might ‘‘confess’’ what you expect
or would like to find, rather than the underlying reality. A totally
unbiasedproceduretocompelthedatato‘‘confessthetruth’’maybe
found in the Phenomenological Universalities (PUN) approach,
recently proposed by P.P. Delsanto and collaborators [1–4], which is
briefly described in the Text S1.
Tumor growth data represent perhaps one of the most critical
instances of such a predicament. In fact, due to the multifaceted
complexity of tumor growth mechanisms and their interactions
with the host tissue, it is important to try to learn as much as
possible from the data about avascular and vascular growth,
metastasis, invasion, etc. Since clinical data are usually restricted
to very few points in time, one tries to gain additional information
from models, such as Multicellular Tumor Spheroids (MTS) [5–8],
or from ex vivo experiments of transplants in lab animals, such as
mice [9–11]. Although MTS experiments boast some inherent
advantages, in the present contribution we are mostly concerned
with the latter, since they are likely to be a better approximation to
in vivo tumoral growth.
The amount of information which can be retrieved from a given
dataset is obviously related to the number of experimental
‘‘points’’, just as in a system of N equations in order to solve for
M unknowns it is necessary that MƒN. In fact, in order to reduce
the effect of experimental errors, it is usually desirable that M%N.
However, if new datapoints are added too close to the old ones,
little information is gained, although the overall statistical accuracy
may improve. For this reason multi-passage experiments (MPE)
are performed, as a tool to study the long-term evolution of grafted
tumor lines: see Figure 1.
Methods
It is generally assumed that tumors originate from a ‘‘seed’’ and
grow by cell duplication, therefore following in the first phase an
exponential growth law. As long as no mechanical nor nutritional
restrictions apply, they go on replicating with a constant
duplication time. After a while, however, host and other
constraints force the development of a necrotic core, and growth
slows down towards some asymptotic level of saturation. This
behaviour is well described by the well known Gompertz law [12],
which has been heuristically used for more than a century in
biology and other disciplines. Most aggressive tumors overcome
nutrients deprivation by means of angiogenesis, and the neo-
vascular network partly supports growth, as discussed by C Guiot
et al. [13], following the model of G.B. West and collaborators
[14–17]. The mechanical pressure induced by the host tissue can
be circumvented by tumor invasion [18] and/or metastatic
diffusion [19].
The progress of growth in the three phases is illustrated in
Figure 2, for the case of Multicellular Tumor Spheroids [20]. The
three phases are also schematically represented in Figure 3, where,
however, the third phase refers to in vivo tumors. The three phases
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U0, U1 and U2, which are described in the Text S1. It is
important to remark, however, that the progression from one class
to the next one must not be understood as a ‘‘shift’’, but rather as a
better approximation (see Table 1 and/or Text S1, Equations 3
and 4) which becomes necessary as the tumor ages.
Let us now assume that we always transplant ‘‘young’’ tumors,
i.e. that a new seed of approximately the same mass m0 is taken
each time after a short time T (e.g. ten days) after each transplant.
Then we can assume to have always an exponential growth law
with approximately the same rate C. It follows that, at the time Dt
after n transplants, i.e. t~nTzDt the tumor mass will be given, at
least as a first approximation, by
mt ðÞ ~azb exp Ct ½  ~azb exp nCT ½  exp CDt ½  ð1Þ
In order to have m(t)=m0 at the outset of each new transplant,
we must have azb exp nCT ½  ~m0 for every value of n, hence
b~m0 and a~m0 (1{exp nCT ½  ). It follows:
Figure 1. A cartoonist’s view of multi-passage experiments. In MPE experiments, tumors grow following the subcutaneous implantation on
the back of a lab animal (usually mice) of ,10
6 tumor cells (from cell cultures or from surgical resection). Tumor cells are then passaged from one
mouse to another by harvesting them from a growing tumor and implanting a given number of them into another healthy animal. Once the tumor
has grown above a certain volume it can be harvested again. This passage of tumor cells is repeated for multiple rounds (McCredie et al. [10] report
the case of a spontaneous mammary tumor in a C3H mouse, from which the first syngenic transplant was done in 1946 and which has been serially
transplanted in the C3H/HeJ strain, reaching in 1971 the 900
th generation!). The idea of taking a very small fraction of a spontaneous tumor mass and
repeateadly transplanting it in a new host seems to reproduce the ideal situation of unlimited resources, and therefore should give us some insight
about unrestricted tumor growth.
doi:10.1371/journal.pone.0005358.g001
Figure 2. The three phases of growth of MTS’s. Temporal evolution of a MTS made of EMT6/Ro mouse mammary carcinoma cells grown in a
confined culture medium. The experimental data (triangles) are taken from Ref. [26]. The ‘‘squares’’ and ‘‘circles’’ correspond to the total numberso f
MTS cells and necrotic cells, respectively. They have been obtained from a mesoscopic simulation [20,27], based on the model of P. P. Delsanto and
collaborators [28–30]. In the figure three regions may be well identified. In the first one, corresponding in the formalism of the Text S1 to the PUN
class U0, there is an almost perfect exponential growth without necrotic core formation. In the second phase, which requires a better approximation
as provided by U1, a bending of the growth curve towards some asymptotic level of saturation can be clearly observed: may be related to the
decreasing availability of nutrients for the growing MTS. In the third phase (U2), a better agreement with the experimental data may be obtained by
considering the next level of approximation (PUN class U2).
doi:10.1371/journal.pone.0005358.g002
Multipassage Tumor Growth
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where t~nTzDt and m0~m 0 ðÞ . Equation (2) shows that the
exponential trend is corrected by a term (exp nCT ½  ), which
accounts for the real age of the tumor and increases at each
transplant, thus accelerating the growth. I.e., at each transplant
the curves become steeper and steeper. Other explanations for the
growth acceleration are also possible, e.g. a lack of accumulated
toxic wastes in the new host and/or the emergence of a more
aggressive subpopulations.
It is interesting to note that the Equation (2) can be viewed as a
Taylor expansion of the Gompertzian law at the first order on Dt.
If, after a limited number n of transplants, we wish to follow the
tumor growth for a large time Dt&T, then it is no longer
possible to assume that we have a purely exponential growth,
since we eventually enter into phases one and two. Thus, for a
best fitting of the experimental curves the formalism of class U2
must be adopted (Text S1, Equation 5). Also, in order to keep
into account the growth acceleration after n passages, as
discussed before, it is convenient to renormalize the physical
time t,u s i n gi n s t e a d
t~t=r ð3Þ
where the acceleration parameter r increases with the number of
transplants n.
Results
As a first instance of application of our approach, we consider
the classical work of G. G. Steel [9], who performed up to ten
‘‘passages’’ of cells from the tumoral line rat fibroadenoma, (see
Figure 4). As discussed in the previous Section, the growth curves
became increasingly steeper at each successive passage, as it can be
inferred also from an analysis of the fitting parameters (see Table 2).
In fact, the y-derivative in t=0is steeper at each successive passage.
However,contrarytowhat one could expect,the asymptoticvalue of
the tumor mass, given by (see Text S1, Equation 5)
y?~ 1z
a0c
b
 {1
c
, ð4Þ
decreases with the number of transplants, since b,0.
Figure 3. Schematic representation of the three UN phases. In U0 the MTS has no core, but starts developing it in U1. The third box represents
three possible evolutionary scenarios for U2 of a tumor in vivo (not of a MTS), i.e. tumor invasion [18,31], angiogenesis [32] and metastatic diffusion [19].
doi:10.1371/journal.pone.0005358.g003
Table 1. Explicit expression of the generating functions b(a), growth rate a(t), and z(t)=ln[y(t)] for the three classes U0, U1, and U2.
Class b(t) a(t) z(t) Remarks
U0 0a 0 z=a0t Exponential growth.
Constant duplication time
U1 baa 0 exp(bt) z=a0/b [exp(bt)21] Gompertz law.
Growth restricted by b.c.’s and/or other
constraints
U2 ba+ca
2 a0 [(1+a0c/b) e
2bt2a0c/b]
21 z=21/c ln[1+a0c/b (12e
bt)] Generalization of the West law [14–17].
Emergence of fractal properties in the
solution
y(t) represents the given dataset, in our case the mass (or volume) of the transplanted tumor at each passage n.
doi:10.1371/journal.pone.0005358.t001
Multipassage Tumor Growth
PLoS ONE | www.plosone.org 3 April 2009 | Volume 4 | Issue 4 | e5358A very interesting follow-up to Steel’s data, which to our
knowledge has not been recognized by other researchers, is the
following. If we ‘‘renormalize’’ his data by means of a simple
rescaling of the time (see Equation (3)), after a suitable choice of
the parameter r we obtain a plot (Figure 4B), in which all the
curves corresponding to the various passages, are collapsed into a
single one, belonging to a very good approximation (R
2=0.98016)
to the PUN class U2 (Text S1, Equation 5). This result, besides its
intrinsic interest (since it means that a tumor after transplant keeps
growing with the same law as before, as discussed previously), is
also of great relevance for our analysis, since it allows the
accumulation of a large number of independent datapoints. It may
also be interesting to observe that the parameter r (which can be
obtained from Equation 3 and Figure 5A) seems to vary linearly
with the number of passages, as shown in Figure 5B. However,
since only the data for four transplants were reported, no firm
conclusion can be reached on this point.
In order to confirm the validity of our approach, we have
extended it to another set of data, from the paper of McCredie et
al. [10]. In their paper the rate of growth of the C3H spontaneous
mammary carcinoma in the mouse is compared with that of its
first and 900
th generation syngeneic transplants (see Figure 6). The
results of our analysis are presented in Figure 6 and the fitting
parameters reported in Table 3.
The MPE growth acceleration has also been observed by other
researchers [21,22] who, unfortunately, did not report the
detailed growth data necessary for a computational analysis. It is
important to remark that the timing of the re-implantation as
well as the dimension reached by the tumor before transplan-
tation may be very different in different experiments. Allowing
the tumor to become large before transplantation invalidates the
assumption of ‘unrestricted growth’ so that the tumor-host
interaction becomes more and more important. This makes
multipassage models interesting for understanding other biolog-
ical mechanisms involved. For instance, after implantation,
subpopulations of other apparently uniform cell populations may
develop, with different properties of proliferation, migration, and
metastasis [23].
In other development, Shen et al. [24] studied the cellular
adjustment of gastric cancer for hepatic metastasis in successive
orthotopic implantation models. The authors compared the
parental cell line (YCC-16) with those obtained by inoculation
into nude mice after 1, 2 and 3 passages (S1L1, S2L2 and S3L3
respectively). They found that, although slower than the parental
line, the doubling time decreased from S1L1 to S3L3 while
clonogenity increased. A progressive increase in the expression of
matrix-metalloproteasis MMP-2 ( i.e. the ability of invasion) was
observed. Also Beniers et al. [21], investigating five lines of renal
Figure 4. MPE results from G. G. Steel. Up to 10 transplants of cells from the tumoral line rat fibroadenoma have been performed, but the curves
corresponding to only four of them have been reported [9]: see (A). As discussed in Methods, the averaged growth curves become increasingly
steeper with successive passages, due to the aging of the newly transplanted tumor cells. By rescaling the time (see Equation 3) with a suitable
choice of the parameter r, we obtain a plot (B), in which all the curves are collapsed into a single one, belonging to the PUN class U2. The fitting
parameters are reported in Table 2.
doi:10.1371/journal.pone.0005358.g004
Table 2. U2 fitting parameters for the data from [9].
Data from [9] 2
nd transpl. 3
rd transpl. 4
th transpl. 10
th transpl.
b 20.013 20.019 20.025 20.043
c [610
25] 0.005 0.012 0.643 0.868
a0c/b [610
23] 20.004 20.005 20.090 20.158
For the second and third transplants the values of c are negligible. They begin
to be appreciable (although still very small) only in subsequent transplants.
Correspondingly the value of p starts being different from one (thus causing a
small level of fractality) only in the latter.
doi:10.1371/journal.pone.0005358.t002
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diameter, were able to show differences in ‘tumor aggressivity’, i.e.
clonogenity, metastasis capacity, etc., between the 5
th and the 15
th
passage.
Discussion
The accelerated growth of transplanted tumors at each
successive passage challenges our understanding of tumor
development. In fact, it is well known that multipassaging in in
vitro setups does not show any remarkable variation in growth rate
[23]; when the same cell line is implanted in animal models, on the
contrary, the growth accelerates significantly at each new passage.
In this contribution we have analyzed two instances of
multipassage experiments in mice: the classical studies of Steel
[9] and of McCredie et al. [10]. As a tool for the analysis of their
datasets we have applied the Phenomenological Universalities
approach [1], which has been fruitfully utilized for application in
different fields (among them: auxology (human growth) [3],
elastodynamics [4] and fracture mechanics [25]). Perhaps the
most important PUN class studied to date is the class UN, which at
the first level (N~0), corresponds to unrestricted exponential
growth. At the level N~1, it yields the Gompertz law, which has
been used, up to few years ago, to fit almost all growth
phenomena. Finally, at the level N~2 (i.e. U2), it successfully
predicts the fractal properties of the solution of the growth
equation at larger times. By applying the PUN approach to the
data of Steel [9] and McCredie et al. [10], we have found that the
class U2 describes extremely well both their datasets, although
with accelerated time scales.
We have also found an explanation for this acceleration. In fact
if, as in the two cases been analyzed, the transplants are always
performed after a short time T, with only relatively few cells
reimplanted into a new healthy and well oxigenated host, their
growth occurs in virtually unrestricted conditions. From a
mathematical point of view we keep having always approximately
the same exponential growth exp CDt ðÞ during each successive
transplantation. But the cumulative effects of a certain number n
of transplants yields a term exp CDt ðÞ , which may be responsible
for the accelerated growth (see Equation 1). In other words, the
tumor cells are as old as the seed taken at the very beginning and
they grow correspondingly faster. This result may have important
consequences in clinical practice. In fact, if one or more
parameters of the system do not change upon transplantation,
they could be considered as a sort of ‘fingerprints’ of a specific
tumor. Then, a very important corollary to our work could
perhaps be the study of metastatic diffusion, since the parameters
of secondary neoplasies would be as well related to the ones of the
primary tumor. Their growth rate would be speeded (as discussed
for the MPE’s), albeit possibly also slowed down by host and other
restrictions. Unfortunately, to our knowledge, no recent data on
MPE’s are available. Further experimental evidence is, of course,
needed, in order to confirm the validity of our conjecture and, in
particular, to ascertain the dependence of the acceleration
parameter r on the passage number, which in Figure 5b has
been assumed to be linear on the basis of a limited number of data
[9].
Figure 5. Variation of the ‘‘acceleration’’ parameter r with the passage number. In (A) the experimental data from [9] have been plotted in
a semi-logarithmic plane and fitted, in a first approximation, with a linear function. For each passage n it is then possible to extract from the angular
coefficients the values of the acceleration parameter r, obtained experimentally (A) and theoretically (by collapsing together the four curves of
Figure 4A as done in Figure 4B).
doi:10.1371/journal.pone.0005358.g005
Table 3. U2 fitting parameters for the data from [10].
Data from [10] Spontaneous 1
st transpl. 900
th transpl.
b 20.030 20.035 20.134
c [610
24] 0.109 0.115 0.219
a0c/b [610
23] 20.906 20.812 20.929
The ‘‘spontaneous’’ growth curve was recorded differently from the successive
transplants (see Figure 6A compared to Figure 6B, 6C, and 6D). Hence a
different value of a0. Due to the very small values of c, the improvement
between U1 and U2 in Figure 6 is only marginal. The normalized values of the
acceleration parameter r for the three cases are 0.27, 0.36 and 1., respectively.
doi:10.1371/journal.pone.0005358.t003
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PLoS ONE | www.plosone.org 5 April 2009 | Volume 4 | Issue 4 | e5358Figure 6. MPE results from McCredie et al. [10]. As many as 900 transplants of cells from the tumoral line C3H rat mammary carcinoma have
been performed, but the curves corresponding to only the original one, the first and the last (900
th) transplant have been reported: (A–C),
respectively. For all of them the fits of the data corresponding to the classes U0, U1, and U2 have been included. There is an obvious improvement
when one goes from U0 to U1 and a much smaller one from U1 to U2. The latter, in fact, yelds an almost perfect agreement with the experimental
data. As in the case of Steel’s data, in (D) the growth curves are normalized and displayed as a single group of data vs. the rescaled time t. Here, as in
Figure 4B, a U2 curve gives an excellent fit to the regrouped data. It is indeed remarkable that after as many as 900 transplants the tumor still grows
with the same law (a part from the time ‘‘rescaling’’). The fitting parameters are reported in Table 3.
doi:10.1371/journal.pone.0005358.g006
Multipassage Tumor Growth
PLoS ONE | www.plosone.org 6 April 2009 | Volume 4 | Issue 4 | e5358Supporting Information
Text S1 The Phenomenological Universalities Approach - The
Fromalism.
Found at: doi:10.1371/journal.pone.0005358.s001 (0.11 MB
DOC)
Author Contributions
Performed the experiments: ASG CG PPD. Analyzed the data: ASG CG
PPD. Contributed reagents/materials/analysis tools: ASG CG PPD.
Wrote the paper: ASG CG PPD.
References
1. Delsanto PP, ed (2007) Universality of Nonclassical Nonlinearity with
applications to NDE and Ultrasonics. New York: Springer.
2. Castorina P, Delsanto PP, Guiot C (2006) Classification Scheme for
Phenomenological Universalities in Growth Problems in Physics and Other
Sciences. Phys Rev Lett 96: 188701.
3. Delsanto PP, Guiot C, Gliozzi AS (2008) Scaling, growth and cyclicity in
biology: a new computational approach. Theor Biol Med Modell 5: 5.
4. Delsanto PP, Ulrich TJ, Gliozzi AS (2008) Elastic Response to Temperature
Variations in Granular Media: a Phenomenological Analysis. Submitted to Appl
Phys Lett.
5. Delsanto PP, Guiot C, Degiorgis PG, Condat AC, Mansury Y, et al. (2004)
Growth model for multicellular tumor spheroids. Appl Phys Lett 85: 4225–4227.
6. Delsanto PP, Griffa M, Condat CA, Delsanto S, Morra L (2005) Bridging the
gap between mesoscopic and macroscopic models: the case of multicellular
tumor spheroids. Phys Rev Lett 94: 148105.
7. Chignola R, Schenetti A, Chiesa E, Foroni R, Sartoris S, et al. (2000)
Forecasting the growth of multicell tumour spheroids: implication for the
dynamic growth of solid tumours. Cell Prolif 33: 219.
8. Pampaloni F, Reynaud EG, Stelzer EHK (2007) The third dimension bridges
the gap between cell culture and live tissue. Nat Rev Mol Cell Biol 8: 839–845.
9. Steel GG (1977) Growth Kinetics of Tumors. Oxford: Clarendon Press.
10. McCredie JA, Sutherland RM (1971) Differences in growth and morphology
between the spontaneous C3H mammary carcinoma in the mouse and its
syngeneic transplants. Cancer 27: 635–642.
11. Kerbel RS (2003) Human tumor xenografts as predictive preclinical models for
anticancer drug activity in humans-better than commonly perceived – But they
can be improved. Canc Biol & Ther 2: S134–S139.
12. Gompertz B (1825) On the nature of the function expressive of the law of human
mortality and on a new mode of determining life contingencies. Phil Trans Roy
Soc Lond 123: 513.
13. Guiot C, DeGiorgis PG, Delsanto PP, Gabriele P, Deisboeck TS (2003) Does
tumor growth follow a ‘universal law’? J Theor Biol 225: 147–283.
14. West GB, Brown JH, Enquist BJ (1999) The fourth dimension of life: Fractal
geometry and allometric scaling of organisms. Science 284: 1677–1679.
15. West GB, Brown JH, Enquist BJ (2001) A general model for ontogenetic growth.
Nature 413: 628–631.
16. Gillooly JF, Charnov EL, West GB, Savage VM, Brown JH (2002) Effects of Size
and Temperature on Developmental Time. Nature 417: 70–73.
17. West GB, Brown JH (2004) Life’s universal scaling laws. Phys Today 57(9):
36–43. Savage VM, Deeds EJ, Fontana W (2008) Sizing Up Allometric Scaling
Theory. PLoS Comput Biol 4(9): e1000171. doi:10.1371/journal.pcbi.1000171.
18. McLean GW, Carragher NO, Avizienyte E, et al. (2005) The role of focal-
adhesion kinase in cancer. A new therapeutic opportunity. Nat Rev Canc 5:
505–515.
19. Sahai E (2007) Illuminating the metastatic process. Nat Rev Canc 7: 737–749.
20. Delsanto PP, Condat C, Pugno N, Gliozzi AS, Griffa M (2008) A multilevel
approach to cancer growth modeling. J Theor Biol 250: 16–24.
21. Beniers AJMC, Peelen WP, Schaafsma HE, Beck JLM, Ramaekers FCS, et al.
(1992) Establishment and characterization of five new human renal tumor
xenografts. Am J Pathol 140: 483–495.
22. Bogden AE, Kelton DE, Cobb WR, Gulkin TA, Johnson RK (1978) Effect of
serial passage in nude athymic mice on the growth characteristics and
chemotherapy responsiveness of 13762 and R3230AC mammary tumor
xenografts. Cancer Res 38: 59–64.
23. Fidler IJ (1978) Tumor heterogeneity and the biology of cancer invasion and
metastasis. Cancer Res 38: 2651–60.
24. Shen X, Jin W, Cui H, Cui X, Noh S, et al. (2006) Cellular adjustment of gastric
cancer for hepatic metastasis in successive orthotopic implantation model.
Cancer Biol Ther 5: 1313–1319.
25. Pugno N, Bosia F, Gliozzi AS, Delsanto PP, Carpinteri A (2008) Phenomeno-
logical approach to mechanical damage growth analysis. Phys Rev E 78 (4):
046013.
26. Freyer JP, Sutherland RM (1986) Regulation of growth saturation and
development of necrosis in EMT6/Ro multicellular spheroids by the glucose
and oxygen supply. Cancer Res 46: 3504.
27. Delsanto PP, Morra L, Delsanto S, Griffa M, Guiot C (2005) Towards a Model
of Local and Collective Mechanisms in Multicellular Tumor Spheroids Growth.
Phys Script T118: 157.
28. Scalerandi M, Romano, Pescarmona GP, Delsanto PP, Condat CA (1999)
Nutrient competition as a determinant for cancer growth. Phys Rev E 59: 2206.
29. Delsanto PP, Romano A, Scalerandi M, Pescarmona GP (2000) Analysis of a
‘‘phase transition’’ from tumor growth to latency. Phys Rev E 62: 2547.
30. Capogrosso Sansone B, Delsanto PP, Magnano M, Scalerandi M (2001) Effects
of anatomical constraints on tumor growth. Phys Rev E 64: 021903.
31. Guiot C, Pugno N, Delsanto PP, Deisboeck TS (2007) Physical aspect of cancer
invasion. Phys Biol 4: 1–6.
32. Folkman J (2006) Angiogenesis. Annu Rev Med 57: 1–18.
Multipassage Tumor Growth
PLoS ONE | www.plosone.org 7 April 2009 | Volume 4 | Issue 4 | e5358